Phase II Clinical Development of New Drugs
Synopsis
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.
Book details
- Edition:
- 1st ed. 2017
- Series:
- ICSA Book Series in Statistics
- Author:
- Naitee Ting, Ding-Geng Chen, Shuyen Ho, Joseph C. Cappelleri
- ISBN:
- 9789811041945
- Related ISBNs:
- 9789811041921
- Publisher:
- Springer Singapore, Singapore
- Pages:
- N/A
- Reading age:
- Not specified
- Includes images:
- Yes
- Date of addition:
- 2018-11-05
- Usage restrictions:
- Copyright
- Copyright date:
- 2017
- Copyright by:
- Springer Singapore, Singapore
- Adult content:
- No
- Language:
-
English
- Categories:
-
Business and Finance, Mathematics and Statistics, Medicine, Nonfiction